PV-0515: GTV delineation of laryngopharyngeal carcinoma on PET is more accurate than on CT and MRI  by Ligtenberg, H. et al.
ESTRO 35 2016                                                                                                                                                    S243 
______________________________________________________________________________________________________ 
between the two groups of treatment. The boost 
administration (p< 0.01), the breast volume (p 0.04), dose 
inhomogeneities (p<0.01) and boost volume (0.04) were 
found to be statistically significant as concerns the 
occurrence of acute skin reaction at the univariate analysis; 
the boost administration (p< 0.01), and hormonotherapy (p 
0.01) at multivariate analysis. Other clinical factors such as 
diabetes or hypertension were not correlated with the 
development of acute skin reaction. G1 and G2/G3 late 
fibrosis were 15.3% and 8.1% in patients received 
chemotherapy and 12.3% and 3.1% in patients who did not 
receive it, with a significant difference (p=0.045) between 
the two groups. Diabetes (p 0.04) and boost administration (p 
<0.01) were also found to be statistically significant on the 
occurrence of late fibrosis, but a multivariate analysis 
adjusted also for clinical tumour characteristics did not show 
any factors correlated to late fibrosis . 
 
Conclusion: The results of our study, according to the large 
randomized trials, confirmed that hypofractionated whole 
breast irradiation is safe, even in patients treated with 
chemotherapy. Chemotherapy didn’t impact on acute toxicity 
but only on late toxicity; however the percentage of G2-G3 
fibrosis is low (8.1 vs 3.1%). Our study confirmed an increase 
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Purpose or Objective: The effect of radiotherapy (RT) on the 
outcome of autologous reconstruction after mastectomy for 
breast cancer is unclear. Advances in technique such as the 
deep inferior epigastric artery perforator (DIEP) flap and 
IMRT may affect the complication rate. We seek to 
retrospectively evaluate the outcomes after flap 
reconstruction at our institution with a focus on radiotherapy 
variables. 
 
Material and Methods: Patients receiving flap reconstruction 
after mastectomy at our institution from 2003-2014 were 
identified in a chart review. Analysis was limited to patients 
with a coded cancer status and who returned for at least one 
follow up visit. The outcome variables analyzed were flap 
loss or any complication (loss, ischemia, hematoma, 
infection). Descriptive data analyzed included age, tumor 
stage, flap type, chemotherapy, and radiation. RT specific 
variables included radiation at an academic medical center vs 
independent radiotherapy facility, 3D-CRT vs IMRT, and 
whether radiation was directed to the internal mammary (IM) 
region. Analyses was on a per-flap basis rather than per 
patient. Statistics were done in SPSS using logistic regression. 
Two prognostic models were generated. The first included all 
patients and analyzed age, stage, flap type, chemotherapy, 
and radiation therapy. The second model included only those 
receiving radiation therapy and included significant factors 
from the first model and the RT variables discussed above.  
 
Results: 291 patients receiving 402 flap procedures met 
inclusion criteria. Mean age was 47.2 years with median 
follow up of 339 days. 93 (21.2%) had transverse rectus 
abdominis (TRAM) flaps, 178 (40.6%) had muscle sparing 
TRAM flaps, and 121 (27.6%) had DIEP flaps. 128 (29.2%) flaps 
were done after mastectomy for benign histology; 62 (14.2%) 
were for DCIS/ LCIS, 69 (15.8%) were for stage I, 88 (20.1%) 
were for stage II, 52 (11.9%) were for stage III, and 3 (0.7%) 
were for stage IV disease. 146 (33.3%) received RT and 187 
(42.7%) received neoadjuvant chemotherapy. Of those 
receiving RT, 42 (28.7%) received 3D-CRT, 38 (26.0%) 
received IMRT, and 66 (44.5%) had unknown RT technique. 28 
(6.9%) flaps failed and 64 (15.9%) flaps had a complication. 
The first model, which included all patients, identified 
increasing cancer stage (p=0.03) as the most important 
variable for flap loss with a hazard ratio of 3.4 for DCIS/LCIS, 
2.1 for stage I, 7.3 for stage II, and 1.8 for stage III compared 
to benign pathology. Age was the only variable associated 
with increased overall complications. In the second model, 
location of RT, RT technique, and IM directed radiation were 
not significant predictors of flap loss or complications. 
 
Conclusion: Cancer stage and age are important predictors 
for flap failure and complications. Use of chest wall radiation 
therapy was not a significant predictor of flap failure.  
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Purpose or Objective: Correct GTV delineation is the basis 
for accurate radiotherapy treatment. It is important to 
determine which imaging modality (CT, MRI or FDG-PET) 
results in most accurate GTV delineation. For clinical 
assessment, both GTV delineations and target volumes 
adjusted for delineation inaccuracies were compared with 
histopathology. 
 
Material and Methods: Twenty-seven patients with a 
laryngeal or hypopharyngeal tumor (T3/T4) were imaged with 
CT, MRI and FDG-PET followed by laryngectomy. Imaging was 
performed in radiotherapy positioning mask. GTV was 
delineated in consensus by three observers on CT and MRI, 
while a semi-automatic delineation was performed on FDG-
PET using an intensity based threshold method. The true 
tumor volume was delineated by one pathologist on whole-
mount histopathological sections. These slides were digitized 
and the specimen was reconstructed in 3-dimensions. The 
tumor contours were non-rigidly transferred to the imaging 
acquired before tumor resection.  
To cover 95% of the outer contour of all tumors, modality 
dependent target margins were derived and added to the 
GTV (Fig. 1a). GTVs and target volumes were compared 




Results: The median tumor volume delineated on pathology 
was 10.5 ml (range: 3.4 ml – 68.6 ml). Median GTVs 
delineated on CT, MRI and PET were 17.5 ml, 15.2 ml and 
14.8 ml, respectively. None of the GTVs fully covered the 
pathological tumor volume with a median tumor coverage of 
93%, 90% and 87%. In several cases, the position of cartilage 
invasion was not recognized, which contributed to missing 
tumor volume.  
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The modality dependent target margins to cover 95% of the 
tumor outer contour were 5.6 mm, 8.7 mm and 6.2 mm and 
resulted in median target volumes of 56 ml, 72 ml and 53 ml 
for CT, MRI and PET, respectively (Fig. 1b). 
 
Conclusion: In all modalities, delineated GTVs overestimated 
tumor volume. Nevertheless, some tumor volume was missed 
in all cases. Automated delineation on PET resulted in the 
smallest target volume compared to manual delineation on 
CT and MRI, while covering an equivalent amount of tumor. 
This study suggests that delineation or segmentation 
inaccuracies can be corrected using a margin between 5.6 
and 8.7 mm. 
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Purpose or Objective: Development of guidelines for the 
delineation of the gross tumor volume (GTV) on MRI is of 
utmost importance to benefit from the increased visibility of 
anatomical details and to achieve a more accurate and 
precise GTV delineation. In the ideal situation, the GTV 
corresponds to the histopathologically determined “true 
tumor volume”. In this work we developed and validated 
guidelines for GTV delineation on MRI by comparison with the 
tumor outline on histopathology as gold standard. 
 
Material and Methods: Twenty-seven patients with T3 or T4 
laryngeal or hypopharyngeal cancer underwent a MRI scan 
before total laryngectomy. After surgery, whole-mount 
hematoxylin-eosin stained (H&E) sections were obtained from 
the surgical specimen. One pathologist delineated all tumor 
tissue on the H&E sections (tumorH&E). The GTV was 
delineated on the MR images (T1 w, Gd-T1 w, T2 w) by three 
independent observers in two sessions. The first session 
(delineation 1) was performed according to clinical practice. 
In the second session (delineation 2) the observers used 
delineation guidelines derived from guidelines for detection 
of cartilage invasion on MRI: Volumes with increased signal 
intensity on T2w images and higher signal intensity on Gd-
T1w images than that of the tumor bulk were not included in 
the GTV. 
The reconstructed specimen was registered to the MR images 
in order to compare the GTV to the tumorH&E in 3D. Volumes 
and overlap parameters were analyzed. Distances between 
the GTV and the tumorH&E were calculated at locations 
where the tumorH&E was outside the GTV. Subsequently, a 
margin that accounted for the underestimation of the tumour 
was determined. Finally, target volumes were created by 
applying this margin to the GTV. 
 
Results: The median GTVs of delineation 1 (19.4 cm3) and of 
delineation 2 (15.8 cm3) were larger than the volume of the 
tumorH&E (10.5 cm3). However, target margins of 10.2 mm 
and 8.3 mm were needed for delineation 1 and 2 , 
respectively, to compensate for the underestimation of the 
tumor at specific locations. By adding this margin to the 
GTVs, the target volumes for delineation 1 (median: 117.6 
cm3, mean: 125.9 cm3, SD: 53.2 cm3) were significantly 
larger than those for delineation 2 (median 76.2 cm3, mean 
85.7 cm3, SD: 43.3 cm3). 
 
Conclusion: GTV delineation guidelines on MRI decreased the 
overestimation of the tumour, resulted in a smaller margin 
around the delineated GTV needed to include all tumor tissue 
and consequently resulted in smaller target volumes with the 
same tumor coverage. 
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Purpose or Objective: The benefit of upfront neck dissection 
(ND) in locally advanced head and neck cancer (HNC) treated 
with primary (chemo-) radiotherapy (CRT) is debated. 
Therefore, we retrospectively compared outcome and 
toxicity between patients with and without upfront ND 
followed by CRT. 
 
Material and Methods: Two-hundred sixty-four consecutive 
patients with HNC without metastases at diagnosis and with 
lymph node stage N2-N3 were included in 2 centers. Patients 
were all treated between January 2002 and December 2012, 
and received definitive CRT in center 1 and upfront ND 
followed by CRT in center 2. Clinical data and outcome were 
assessed retrospectively. Toxicity was scored using the LENT-
SOMA scale at 6, 12, 18 and 24 months after the end of 
treatment.Both patient groups were compared using a Chi-
square test for categorical variables or a Mann-Whitney U 
test for continuous variables. Descriptive statistics on overall 
survival (OS) is based on Kaplan Meier estimates. For all other 
time-to-event outcomes, cumulative incidence function (CIF) 
estimates were calculated. The difference between both 
groups on the different outcomes was analyzed using 
multivariable models, including group and prognostic patient- 
or tumor characteristics on which the 2 groups were 
different. All tests were two-sided, and a p-value of less than 
0.05 was considered statistically significant. 
 
Results: We included 150 patients in the group without ND 
(center 1) and 114 patients in the group with upfront ND 
(center 2). The group comparison is given in Table 1.  
 
